Related Experiment Video
Updated: Sep 25, 2026

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
Published on: September 10, 2018
Morphinan derivatives--A review of the recent patent literature
Stefania Gagliardi1, Giulio Dondio, Giuseppe A M Giardina
1NiKem Research Srl, Via Zambeletti 25, 20021 - Baranzate di Bollate, Milan, Italy. stefania.gagliardi@nikemresearch.com
Abstract:
Alkaloids extracted from the Papaverum somniferum are among the most powerfully acting and clinically used drugs for diseases of the central nervous system, in particular for pain. The basic ring system, common to these opiate alkaloids, is the morphinan skeleton, which in the last 50 years has been chemically manipulated to obtain compounds with improved potency and increased selectivity toward different populations of opioid receptors. Despite a huge amount of research, interest surrounding these compounds is still high. This review will discuss the patent applications published from January 2001 to June 2002, focusing on new chemical entities that could become drugs over the next few years, new chemical processes for the production of the morphinans currently used in therapy, novel formulations and combined compositions.
More Related Videos
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Opioid Receptors: Overview
Analgesia and Pain Management
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

